Jane Street’s Bone Biologics BBLG Stock Holding History

Jane Street’s Portfolio BBLG Stock Details BBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	-$37K	–	9643
2022 Q1	$37K	Buy	+9	New	+$32.6K	﹤0.01%	9776

Other funds holding BBLG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's BBLG Position: Q2 2022 in Review

Jane Street sold out of Bone Biologics (BBLG) in Q2 2022, closing a stake of 9 shares — an estimated $37K sold.

Jane Street first reported a position in BBLG in Q1 2022 and held it in 1 quarter. The position peaked at $37K in Q1 2022. 3 funds tracked by Wall St. Rank hold BBLG as of Q2 2022.

Jane Street reported no remaining Bone Biologics position as of Q2 2022 after selling out during the quarter.
Jane Street sold 9 Bone Biologics shares in Q2 2022, an estimated $37K.
Jane Street first reported a position in Bone Biologics in Q1 2022 and held it in 1 quarter.
Jane Street's Bone Biologics position peaked at $37K in Q1 2022.
3 funds tracked by Wall St. Rank held Bone Biologics as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.